Metagenomi Inc (MGX) PT Lowered to $9 at Jefferies Nov 18, 2025 04:30AM
Metagenomi, Inc. (MGX) Tops Q3 EPS by 25c Nov 11, 2025 04:56PM
Metagenomi cuts workforce 25%, names new CEO amid pipeline focus Nov 11, 2025 04:03PM
Metagenomi reports curative FVIII activity in primates for hemophilia A therapy Nov 11, 2025 04:01PM
Oracle, Silver Lake, MGX to own 45% of TikTok U.S. - CNBC Sep 25, 2025 01:48PM


Aug 12, 2025 06:04PM Metagenomi, Inc. (MGX) Tops Q2 EPS by 18c
Jun 18, 2025 12:15PM CRISPR Therapeutics (CRSP) gains on continued chatter
Jun 17, 2025 11:28AM Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital
May 14, 2025 05:20PM Metagenomi, Inc. (MGX) Tops Q1 EPS by 7c
Apr 3, 2025 06:47AM Metagenomi Inc (MGX) PT Lowered to $7 at H.C. Wainwright
Mar 13, 2025 06:20AM Metagenomi (MGX) Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
Jan 16, 2025 08:56AM Metagenomi (MGX) Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
Nov 14, 2024 04:59PM Metagenomi, Inc. (MGX) Tops Q3 EPS by 24c
Oct 15, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Metagenomi Inc (MGX)
Sep 6, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on Metagenomi Inc (MGX)
Sep 4, 2024 12:08PM TD Cowen Reiterates Buy Rating on Metagenomi Inc (MGX)
Sep 3, 2024 04:07PM Metagenomi (MGX) Reports Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
Aug 21, 2024 06:42AM Metagenomi Inc (MGX) PT Lowered to $7 at H.C. Wainwright
Aug 15, 2024 04:55PM Metagenomi, Inc. (MGX) Tops Q2 EPS by 41c
Jul 15, 2024 08:33AM H.C. Wainwright Reiterates Buy Rating on Metagenomi Inc (MGX)